Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy and safety of ustekinumab in the treatment of oral ulcers (OU) in patients with Behcet's Disease

Trial Profile

Efficacy and safety of ustekinumab in the treatment of oral ulcers (OU) in patients with Behcet's Disease

Completed
Phase of Trial: Phase III

Latest Information Update: 25 Apr 2018

At a glance

  • Drugs Ustekinumab (Primary)
  • Indications Behcet's syndrome; Oral ulcer
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Apr 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top